Burkholder JK - Search Results

1

Cytokine transgene expression and promoter usage in primary CD34+ cells using particle-mediated gene delivery.

Ye ZQ, Qiu P, Burkholder JK, Turner J, Culp J, Roberts T, Shahidi NT, Yang NS. Ye ZQ, et al. Among authors: burkholder jk. Hum Gene Ther. 1998 Oct 10;9(15):2197-205. doi: 10.1089/hum.1998.9.15-2197. Hum Gene Ther. 1998. PMID: 9794204

2

Establishment of an adherent cell feeder layer from human umbilical cord blood for support of long-term hematopoietic progenitor cell growth.

Ye ZQ, Burkholder JK, Qiu P, Schultz JC, Shahidi NT, Yang NS. Ye ZQ, et al. Among authors: burkholder jk. Proc Natl Acad Sci U S A. 1994 Dec 6;91(25):12140-4. doi: 10.1073/pnas.91.25.12140. Proc Natl Acad Sci U S A. 1994. PMID: 7527553 Free PMC article.

3

In vivo cytokine gene transfer by gene gun reduces tumor growth in mice.

Sun WH, Burkholder JK, Sun J, Culp J, Turner J, Lu XG, Pugh TD, Ershler WB, Yang NS. Sun WH, et al. Among authors: burkholder jk. Proc Natl Acad Sci U S A. 1995 Mar 28;92(7):2889-93. doi: 10.1073/pnas.92.7.2889. Proc Natl Acad Sci U S A. 1995. PMID: 7708743 Free PMC article.

4

Transient promoter activity in primary rat mammary epithelial cells evaluated using particle bombardment gene transfer.

Thompson TA, Gould MN, Burkholder JK, Yang NS. Thompson TA, et al. Among authors: burkholder jk. In Vitro Cell Dev Biol. 1993 Feb;29A(2):165-70. doi: 10.1007/BF02630949. In Vitro Cell Dev Biol. 1993. PMID: 8386156

5

Expression of a tumor-reactive antibody-interleukin 2 fusion protein after in vivo particle-mediated gene delivery.

Nicolet CM, Burkholder JK, Gan J, Culp J, Kashmiri SV, Schlom J, Yang NS, Sondel PM. Nicolet CM, et al. Among authors: burkholder jk. Cancer Gene Ther. 1995 Sep;2(3):161-70. Cancer Gene Ther. 1995. PMID: 8528959

6

In vivo particle-mediated cytokine gene transfer into canine oral mucosa and epidermis.

Keller ET, Burkholder JK, Shi F, Pugh TD, McCabe D, Malter JS, MacEwen EG, Yang NS, Ershler WB. Keller ET, et al. Among authors: burkholder jk. Cancer Gene Ther. 1996 May-Jun;3(3):186-91. Cancer Gene Ther. 1996. PMID: 8725883

7

Particle-mediated gene transfer of granulocyte-macrophage colony-stimulating factor cDNA to tumor cells: implications for a clinically relevant tumor vaccine.

Mahvi DM, Burkholder JK, Turner J, Culp J, Malter JS, Sondel PM, Yang NS. Mahvi DM, et al. Among authors: burkholder jk. Hum Gene Ther. 1996 Aug 20;7(13):1535-43. doi: 10.1089/hum.1996.7.13-1535. Hum Gene Ther. 1996. PMID: 8864754

8

Development of human granulocyte-macrophage colony-stimulating factor-transfected tumor cell vaccines for the treatment of spontaneous canine cancer.

Hogge GS, Burkholder JK, Culp J, Albertini MR, Dubielzig RR, Keller ET, Yang NS, MacEwen EG. Hogge GS, et al. Among authors: burkholder jk. Hum Gene Ther. 1998 Sep 1;9(13):1851-61. doi: 10.1089/hum.1998.9.13-1851. Hum Gene Ther. 1998. PMID: 9741424 Clinical Trial.

9

Preclinical development of human granulocyte-macrophage colony-stimulating factor-transfected melanoma cell vaccine using established canine cell lines and normal dogs.

Hogge GS, Burkholder JK, Culp J, Albertini MR, Dubielzig RR, Yang NS, MacEwen EG. Hogge GS, et al. Among authors: burkholder jk. Cancer Gene Ther. 1999 Jan-Feb;6(1):26-36. doi: 10.1038/sj.cgt.7700015. Cancer Gene Ther. 1999. PMID: 10078961

10

Granulocyte-macrophage colony-stimulating factor mRNA stabilization enhances transgenic expression in normal cells and tissues.

Rajagopalan LE, Burkholder JK, Turner J, Culp J, Yang NS, Malter JS. Rajagopalan LE, et al. Among authors: burkholder jk. Blood. 1995 Oct 1;86(7):2551-8. Blood. 1995. PMID: 7670100 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

23 results

Search Page

Filters